Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations

被引:3
|
作者
Choi, Joseph Do Woong [1 ]
Tucker, Katherine M. [2 ]
Lee, Tack Tsiew [1 ]
Chong, Guan C. [1 ]
机构
[1] Australian Natl Univ, Sch Med, Canberra Hosp, Acad Surg Unit, Canberra, ACT 2601, Australia
[2] Prince Wales Hosp, Hereditary Canc Serv, Randwick, NSW 2031, Australia
关键词
paraganglioma; pheochromocytoma; hereditary; succinate dehydrogenase subunit D (SDHD) mutation; rearranged during transfection (RET) mutation; ENDOCRINE NEOPLASIA TYPE-2; GENETICS; HEAD;
D O I
10.1002/hed.23598
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Hereditary paraganglioma-pheochromocytoma syndromes (PGL/PCC) are rare tumors arising from neuroendocrine cells. Methods and Results. The proband, a 59-year-old white man and his 42-year-old elder son had a medical history of bilateral carotid body PGL and both presented for treatment of abdominal PGLs. His 36-year-old daughter had excision of recurrent malignant carotid body PGL and vertebral metastasis. His 33-year-old youngest son presented for excision of a unilateral carotid body PGL. All 4 members had succinate dehydrogenase subunit D (SDHD) mutations, whereas the proband and youngest son also had concurrent rearranged during transfection (RET) mutation. Conclusion. This is the first report of PGL/PCC with SDHD and RET mutations. The role of the RET gene as a modifier remains speculative. Additionally, the family pedigree suggests maternal inheritance of disease from the probands' paternal grandmother. Clinicians should refer PGL/PCC families for mutation analysis as well as being alert to changes in the classification of mutations. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:E99 / E102
页数:4
相关论文
共 50 条
  • [1] Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
    Gill, Anthony J.
    Benn, Diana E.
    Chou, Angela
    Clarkson, Adele
    Muljono, Anita
    Meyer-Rochow, Goswin Y.
    Richardson, Anne Louise
    Sidhu, Stan B.
    Robinson, Bruce G.
    Clifton-Bligh, Roderick J.
    HUMAN PATHOLOGY, 2010, 41 (06) : 805 - 814
  • [2] Metastatic paraganglioma of the spine associated with autosomal dominant hereditary paraganglioma-pheochromocytoma syndrome
    Castillejo-Adalid, Luis A.
    Valenzuela-Hernandez, Teodulo
    Juarez-Aguilar, Fany G.
    Moreno-Ortiz, Emmanuel
    Maciel-Ramos, Emmanuel
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2022, 29
  • [3] The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes
    Udager, Aaron M.
    Magers, Martin J.
    Goerke, Dayna M.
    Vinco, Michelle L.
    Siddiqui, Javed
    Cao, Xuhong
    Lucas, David R.
    Myers, Jeffrey L.
    Chinnaiyan, Arul M.
    McHugh, Jonathan B.
    Giordano, Thomas J.
    Else, Tobias
    Mehra, Rohit
    HUMAN PATHOLOGY, 2018, 71 : 47 - 54
  • [4] The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste
    Hall, Michael J.
    Forman, Andrea D.
    Obeid, Elias
    JAMA ONCOLOGY, 2017, 3 (12) : 1739 - 1740
  • [5] 18F-DOPA PET/CT in the evaluation of hereditary paraganglioma-pheochromocytoma syndromes
    Grassetto, G.
    Marzola, M. C.
    Chondrogiannis, S.
    Rampin, L.
    Massaro, A.
    Opocher, G.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S205 - S206
  • [6] The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste Reply
    Ikoma, Naruhiko
    Araujo, Dejka
    Roland, Christina L.
    JAMA ONCOLOGY, 2017, 3 (12) : 1740 - 1740
  • [7] SDHB expression in paraganglioma-pheochromocytoma syndromes: advantages and limits
    Fassina, A.
    Tricarico, P.
    Schiavi, F.
    Guzzardo, V.
    Cappellesso, R.
    Bombonato, M.
    Opocher, G.
    Fassan, M.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 153 - 153
  • [8] An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
    Gimenez-Roqueplo, A. -P.
    Dahia, P. L.
    Robledo, M.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (05) : 328 - 333
  • [9] Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations
    Baysal, Bora E.
    Maher, Eamonn R.
    ENDOCRINE-RELATED CANCER, 2015, 22 (04) : T71 - T82
  • [10] Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
    Huang, Yiqiang
    Wang, Lin-ang
    Rio, Qiubo
    Pang, Jian
    Wang, Luofu
    Yi, Yuting
    Zhang, Jun
    Zhang, Yao
    Chen, Rongrong
    Lan, Weihua
    Zhang, Dianzheng
    Jiang, Jun
    ENDOCRINE CONNECTIONS, 2018, 7 (12): : 1217 - 1225